logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
19/12/2025
Ideal Car: In the 2025 Automotive Industry Peak Awards, the Ideal i6 was awarded the 2025 Best Quality Innovation Model Award.
Latest
2 m ago
Hong Kong Monetary Authority: The transaction amount of stored value payment tools in the third quarter was HK$ 268.9 billion, a decrease of 5.9% compared to the previous quarter.
3 m ago
Bank of Italy: It is expected that the GDP will grow by 0.6% in 2025-26 and by 0.8% in 2027.
3 m ago
The Bank of Italy has raised its economic growth forecast for 2027, with consumer spending being the main driving factor.
3 m ago
South China Futures Co., Ltd (02691.HK): Public offering in Hong Kong oversubscribed by 1.91 times, with a sale price of HK$12 per share.
3 m ago
According to the documents of the Hong Kong Stock Exchange, Suzhou Zejing Biopharmaceutical Co., Ltd. has submitted an application for listing to the Hong Kong Stock Exchange, with China International Capital Corporation as the exclusive sponsor.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.